Medpace Holdings (MEDP) Cash from Investing Activities (2015 - 2026)
Medpace Holdings' (MEDP) quarterly Cash from Investing Activities came in at -$23.9 million in Q2 2026, down 296.76% on a YoY basis from $12.1 million in Q2 2025, and down 253.96% quarter-over-quarter from -$6.7 million in Q1 2026.
Analysis
Medpace Holdings (MEDP) Cash from Investing Activities (2015 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has reported Cash from Investing Activities for 12 consecutive years, with -$23.9 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cash from Investing Activities fell 296.76% year-over-year to -$23.9 million; the trailing twelve-month figure through Jun 2026 stood at -$45.8 million (down 34.39% YoY), and the FY2025 full-year result was -$31.1 million, down 10.0% from the prior year.
- Cash from Investing Activities eased to -$23.9 million in Q2 2026 per MEDP's latest filing, from -$6.7 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $2.5 million in Q1 2024 and bottomed at -$23.9 million in Q2 2026.
- Historically, Cash from Investing Activities has averaged -$9.1 million across 5 years, with a median of -$8.9 million in 2022.
- The sharpest annual moves came in 2024 and 2025: Cash from Investing Activities jumped 126.62% in 2024, then tumbled 494.74% in 2025.
- Over 5 years, Cash from Investing Activities stood at -$9.2 million in 2022, then advanced by 13.26% to -$8.0 million in 2023, then grew by 5.44% to -$7.6 million in 2024, then jumped by 40.85% to -$4.5 million in 2025, then slumped by 433.98% to -$23.9 million in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$23.9 million, -$6.7 million, and -$4.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | -381.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | -23.89 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | -108.34 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 28.10 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | -7.00 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 11.09 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -55,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -55,941.69 |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -23,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -23.89 Mn |
| Mar 31, 2026 | -6.75 Mn |
| Dec 31, 2025 | -4.47 Mn |
| Sep 30, 2025 | -10.66 Mn |
| Jun 30, 2025 | -6.02 Mn |
| Mar 31, 2025 | -9.99 Mn |
| Dec 31, 2024 | -7.56 Mn |
| Sep 30, 2024 | -10.49 Mn |
| Jun 30, 2024 | -12.79 Mn |
| Mar 31, 2024 | 2.53 Mn |
| Dec 31, 2023 | -8.00 Mn |
| Sep 30, 2023 | -8.66 Mn |
| Jun 30, 2023 | -8.47 Mn |
| Mar 31, 2023 | -9.50 Mn |
| Dec 31, 2022 | -9.22 Mn |
| Sep 30, 2022 | -7.19 Mn |
| Jun 30, 2022 | -11.13 Mn |
| Mar 31, 2022 | -11.21 Mn |
| Dec 31, 2021 | -9.12 Mn |
| Sep 30, 2021 | -6.60 Mn |